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Abstract
The HIV promoter within the viral long terminal repeat (LTR) orchestrates many aspects of the viral life cycle, from the
dynamics of viral gene expression and replication to the establishment of a latent state. In particular, after viral integration
into the host genome, stochastic fluctuations in viral gene expression amplified by the Tat positive feedback loop can
contribute to the formation of either a productive, transactivated state or an inactive state. In a significant fraction of cells
harboring an integrated copy of the HIV-1 model provirus (LTR-GFP-IRES-Tat), this bimodal gene expression profile is
dynamic, as cells spontaneously and continuously flip between active (Bright) and inactive (Off) expression modes.
Furthermore, these switching dynamics may contribute to the establishment and maintenance of proviral latency, because
after viral integration long delays in gene expression can occur before viral transactivation. The HIV-1 promoter contains cis-
acting Sp1 and NF-kB elements that regulate gene expression via the recruitment of both activating and repressing
complexes. We hypothesized that interplay in the recruitment of such positive and negative factors could modulate the
stability of the Bright and Off modes and thereby alter the sensitivity of viral gene expression to stochastic fluctuations in
the Tat feedback loop. Using model lentivirus variants with mutations introduced in the Sp1 and NF-kB elements, we
employed flow cytometry, mRNA quantification, pharmacological perturbations, and chromatin immunoprecipitation to
reveal significant functional differences in contributions of each site to viral gene regulation. Specifically, the Sp1 sites
apparently stabilize both the Bright and the Off states, such that their mutation promotes noisy gene expression and
reduction in the regulation of histone acetylation and deacetylation. Furthermore, the NF-kB sites exhibit distinct properties,
with kB site I serving a stronger activating role than kB site II. Moreover, Sp1 site III plays a particularly important role in the
recruitment of both p300 and RelA to the promoter. Finally, analysis of 362 clonal cell populations infected with the viral
variants revealed that mutations in any of the Sp1 sites yield a 6-fold higher frequency of clonal bifurcation compared to
that of the wild-type promoter. Thus, each Sp1 and NF-kB site differentially contributes to the regulation of viral gene
expression, and Sp1 sites functionally ‘‘dampen’’ transcriptional noise and thereby modulate the frequency and
maintenance of this model of viral latency. These results may have biomedical implications for the treatment of HIV latency.
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Introduction
HIV-1 can establish rare, latent infections in cells, and the
resulting viral reservoirs represent the most significant barrier to
elimination of virus from a patient since they persist for decades
and can reactivate at any time [1]. After HIV enters a cell, it
integrates its genetic material into the host genome and utilizes
host cell transcriptional machinery to regulate its gene expression.
Briefly, initial expression from the HIV long terminal repeat
(LTR) promoter is hindered by stalling of RNA polymerase II
(RNAPII) [2], which results in a high frequency of abortive
transcripts [3]. However, a low leaky or basal transcription
generates a small fraction of fully elongated transcripts that yield
viral mRNA encoding a positive regulator, the transcriptional
activator (Tat) [4]. Tat binds to cyclin T1, a unit of the
endogenous positive transcriptional elongation factor B (P-TEFb)
[5,6], and the Tat:P-TEFb complex binds to an RNA motif in
stalled HIV transcripts known as the transactivation response
element (TAR) [7]. In this complex, P-TEFb phosphorylates the
C-terminal domain of RNAPII, thereby enhancing its processivity
and enabling the efficient generation of fully elongated transcripts
[2]. The net result is a strong positive feedback loop of Tat-
mediated transactivation that amplifies viral transcriptional
elongation nearly 100-fold [8].
We previously explored whether stochastic delays in the onset of
HIV-1 Tat expression contribute to the formation of latent viral
infections [9]. Genetic noise is an inherent and significant process
in gene expression in bacteria [10,11], yeast [12–15], and
mammals [9,16,17]. In particular, stochastic effects most com-
monly become important in slow chemical reactions or with low
concentrations of chemical species, both of which apply early in
HIV gene expression when basal expression and Tat concentra-
tions are low. Using a lentiviral model of the Tat-mediated positive
feedback loop (LTR-GFP-IRES-Tat,o rLGIT), we have demon-
strated that random fluctuations in Tat levels could result in clonal
cell populations that exhibited two distinct viral gene expression
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bifurcation (PheB) [9]. Such bifurcating clonal populations,
expanded from single cells each harboring a single viral integration
position, exhibit dynamic gene expression behavior, with cells
continuously switching between the two modes of gene expression.
Moreover, integrated provirus can remain Off for extended
periods of time before switching to a Bright expression level,
suggesting that long delays in transactivation could contribute to
postintegration viral latency [18,19]. Here, we expand upon this
work to study how host transcription factor binding sites at the
HIV-1 LTR contribute to both the level of viral gene expression
and noise in that gene expression, with a focus on potential
implications for the establishment and persistence of viral latency.
Following preferential HIV-1 integration into regions of active
chromatin [9,18,20,21], transcription factor binding sites in the
LTR recruit activating and repressing host cell transcription
factors and thereby likely influence the basal viral gene expression,
the maximal inducible rate of viral expression, and the dynamics
of switching between these two states. In particular, binding sites
for NF-kB, Sp1, YY1/LBP-1, AP-1, and other factors recruit
chromatin modifying complexes to the HIV promoter (Figure 1A)
[22,23]. Activating complexes may recruit histone acetyltransfer-
ases (HATs) and thus contribute to stabilizing the transcriptionally
active state of HIV in either a Tat- dependent or independent
manner [24,25]. Alternatively, numerous repressing complexes
may recruit histone deacetylases (HDACs) that stabilize the
transcriptionally inactive mode by chromatin deacetylation or
via competition with activating complexes [3,22].
In particular, the prototypical HIV clade B promoter contains
two kB-binding sites and three tandem Sp1-binding sites (Figure 1A
and 1B), all of which have the potential to recruit either repressing
or activating complexes (Figure 1C). For example, the NF-kB p50-
p50 homodimer complex binds to the kB binding sites and can
recruit the repressive HDAC1 and HDAC3 factors [3,26].
Alternatively, binding of the activating NF-kB p50-RelA heterodi-
mer [27] enables interaction with p300 [28,29], a HAT that is
required for full Tat activity [24,30]. The p50-RelA heterodimer
can also interact with P-TEFb [31] and thereby aid RNAPII
processivity [32,33]. Similarly, Sp1 can interact with both HDACs
and HATs [34,35], and thus may mediate both repressing and
activating transcriptional mechanisms.
Modulation of HIV gene expression with cytokines and other
pharmacological agents that function via NF-kB or Sp1 dependent
mechanisms further demonstrates the importance of these sites to
promoter regulation. For example, tumor necrosis factor alpha
(TNF-a) activates HIV transcription by increasing the nuclear
concentration of RelA, thereby increasing the availability of p50-
RelA to bind kB sites [36]. In addition, trichostatin A (TSA)
activates transcription by inhibiting class I and II HDACs, which
otherwise repress HIV gene expression by maintaining chromatin
deacetylation [37,38]. Since both Sp1 and kB sites facilitate
recruitment of class I HDACs [3,34,39], both NF-kB- and Sp1-
mediated repression are targets for TSA activation.
A number of important studies demonstrate that the deletion or
mutation of any of the Sp1 or kB elements compromises the rates
of gene expression and/or viral replication [40–45], though the
effects of mutations or deletions on the establishment of latency
were not explored. Moreover, although kB sites have been
demonstrated to play important roles in both HIV activation and
proviral latency [3,32,33,46,47], the interplay between multiple
transcription factor binding sites, gene expression noise [9], and
the choice between transcriptional activation and viral replication
vs. genetic silencing and latency have not been examined. As we
hypothesize that PheB integrants are likely poised at the edge
between repressive and activating mechanisms, these proviruses
may be highly sensitive to other sources of noise, including the
dynamic competition between the recruitment of repressing and
activating complexes at the Sp1 and kB sites (Figure 1C).
Here, we examine the roles of the kB and Sp1 elements in the
context of a model of postintegration HIV latency to dissect the
contributions of each site to gene expression dynamics, transcrip-
tional activation and repression, noise in gene expression, and
potentially proviral latency. Using gene expression analysis,
pharmacological perturbations, chromatin immunoprecipitation,
and analysis of transcriptional initiation and elongation, we
demonstrate that each Sp1 site plays a significant role in the
persistence of both active and inactive expression states.
Furthermore, the two kB sites differentially recruit transcriptional
regulators, where kB site I contributes more to transcriptional
activation through the recruitment of p50-RelA heterodimer,
while kB site II has a bias for the repressing p50-p50 complex.
Interestingly, these sites play unique, and at times synergistic, roles
in the transcriptional regulation events that underlie gene
expression noise and potentially clinical HIV latency.
Results
Generation and analysis of lentivirus with Sp1 and kB
mutations
Inactivating point mutations [48–50] were introduced into each
of the Sp1 and kB sites within the LTR of the LGIT virus plasmid
(Figure 1B). These mutant versions of LGIT include an inactivating
mutation of Sp1 site I (mutI Sp1), Sp1 site II (mutII Sp1), Sp1 site III
(mutIII Sp1), all Sp1 sites (mutALL Sp1), kB site I (mutI NF-kB), kB
site II (mutII NF-kB), a combination of kB sites I and II (mutI&II
NF-kB), a full deletion of both kB sites (del NF-kB), and a
combination of Sp1 site III and kB site I (mutIII Sp1/mutI NF-kB).
After viral production, Jurkat cells were infected at a low
multiplicity of infection (MOI ,0.05–0.10), a level demonstrated
to yield a polyclonal population of infected cells with a broad
range of single viral integration sites per cell [9]. Viral LTR
Author Summary
After HIV genome integration into the host chromosome,
the viral promoter coordinates a complex set of inputs to
control the establishment of viral latency, the onset of viral
gene expression, and the ensuing gene expression levels.
Among these inputs are chromatin structure at the site of
integration, host transcription factors, and the virally
encoded transcriptional regulator Tat. Importantly, tran-
scriptional noise from host and viral transcriptional
regulators may play a critical role in the decision between
replication versus latency, because stochastic fluctuations
in gene expression are amplified by a Tat-mediated
positive transcriptional feedback loop. To evaluate the
individual contributions of key transcription factor binding
elements in gene expression dynamics, we employ model
HIV viruses with mutations introduced into numerous
promoter elements. Extensive analysis of gene expression
dynamics and transcription factor recruitment to the viral
promoter reveals that each site differentially contributes to
viral gene expression and to the establishment of a low
expression state that may contribute to viral latency. This
systems-level approach elucidates the synergistic contri-
butions of host and viral factors to the dynamics,
magnitudes, and stochastic effects in viral gene expres-
sion, as well as provides insights into mechanisms that
contribute to proviral latency.
Sp1 and kB Sites Regulate HIV Latency
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the initial infection. Gene expression was detectable 48 hours
post-infection, the first time point analyzed, and progressively
increased over the course of a week. This timing is consistent with
in vivo reports that reveal that viral production initiates
approximately two days after infection following the viral ‘‘eclipse
phase’’ [51]. Histograms for LGIT and mutant versions revealed a
Bright, transactivated population and an Off population that
included infected, inactive cells in addition to a larger population
of uninfected cells (Figure S1B). However, for two LGIT variants,
mutALL Sp1 and mutIII Sp1/mutI NF-kB, a Bright population of
cells was not detected (Figure S1B), and these two mutant
combinations were not further studied.
Mutants demonstrate activating roles for each Sp1 site
For the 21-day time course experiments, heat maps depicting
the GFP intensity distribution of the infected cell populations
indicate that mutations in the Sp1 sites substantially impact GFP
expression (Figure S1A). The WT and mutant LGIT variants
exhibited a similar temporal onset of gene expression and reached
a maximum in the mean position of their bright peaks (Bright
Mean)—a metric of gene expression in the Tat feedback loop—10
days after infection (Figure 2A). Importantly, mutation of any of
the Sp1 sites (mutI Sp1, mutII Sp1, and mutIII Sp1) resulted in
dramatic 40–50% decreases in the Bright Mean levels (Figure 2A).
These results indicate that each Sp1 site has a considerable role in
the transcriptional activation of the proviral LTR, with Sp1 site III
appearing to have a slightly larger contribution than Sp1 site I or
II (p,0.05 for each day after day 6).
While the Bright Mean characterizes the strength of Tat
transactivation within the positive feedback loop, a smaller, less
stable population of LGIT cells exhibits intermediate levels of gene
expression. We have previously demonstrated that stochastic
effects in gene expression are most evident at these intermediate
levels of Tat and contribute to switching between Bright and Off
modes [9]. Therefore, the fraction of cells that expresses GFP at
intermediate or Mid fluorescence levels (i.e., the Mid:On ratio,
where On is the sum of Mid and Bright regions, Figure 1C) is a
measure of stochastic fluctuations in Tat expression. Mutations
that further stabilize the Off or Bright mode would be predicted to
Figure 1. Architecture of Sp1 and kB Regulatory Elements within HIV-1 LTR. (A) Schematic representing the U3, R, and U5 regions of the
HIV LTR. Several important transcriptional elements within the U3 region are shown, including the TATA box (227/223) and binding elements Sp1
(255/246, 266/257, and 277/268), kB( 290/281 and 2104/295), LBP-1 (216/+27), LEF-1 (237/251), NFAT-1 (2254/2216), and AP-1 (2247/
2222). (B) Inactivating point mutations in the Sp1 and kB sites were engineered into the LGIT lentiviral plasmid. Mutation sites for kB [50] and Sp1
[48,49] were previously described, and primer sequences are supplied in Table S1. Infections of LGIT and mutant lentivirus are detailed in Materials
and Methods. (C) A sample bifurcating clonal population of LGIT-infected Jurkats. Gene expression of GFP and Tat is amplified by Tat-transactivation,
and the two modes of fluorescence (Off and Bright) correspond to the two states in this genetic circuit (Off and On). We hypothesize that
transcriptional bimodality is regulated by repressing and activating complexes, which stabilize Off and Bright modes, respectively. These factors may
include repressing histone deacetylase (HDACs, including HDAC1) complexes2recruited by p50-p50 homodimer (at kB sites) [3] and Sp1 protein (at
Sp1 sites)2and activating histone acetyltransferases (HATs, including p300)2recruited in conjunction with p50-RelA heterodimer (kB sites) and Sp1
protein (at Sp1 sites). The largely unstable Mid region, which may result from stochastic fluctuations in Tat and switching between Off and Bright
states, is regulated by dynamic interplay between repressing and activating complexes. See Figure S6 for further detail.
doi:10.1371/journal.ppat.1000260.g001
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two stabilized states. In contrast, mutations that destabilize the Off
and Bright modes would yield an increase in the Mid:On ratio, via
increasing the rate of flipping between the two ‘‘less stable’’
transcriptional states and thereby creating a noisier promoter. At
early times after infection, the Mid:On ratio is high, as the gene
expression of infected cells ramps up, but it later settles into an
informative steady state value (Figure 2B). Over the three week
time course, the Mid:On ratios for each of the Sp1 mutants remain
3- to 4-fold higher than WT. These data indicate that each of the
Sp1 sites in the WT promoter may stabilize the Bright and
potentially the Off mode, and that a reduction of this stabilization
(consistent with the observed decrease in the Bright Mean position,
Figure 2A) may increase the rates of switching between Off and
Bright expression modes. Thus, based on the Mid:On ratio as a
metric for stochastic behavior in the Tat-feedback circuit, the Sp1
sites appear to control promoter noise, with potential implications
for viral latency.
Mutants suggest distinct roles for the two kB sites
In parallel experiments to the LGIT Sp1 mutants, mutation of
each of the two kB sites in the HIV promoter reveals the roles of
each site in stabilizing the Bright modes (Bright Mean) as well as
dynamic flipping between modes (Mid:On ratio). Compared to
WT LGIT, the kB site I mutant (mutI NF-kB) exhibited a decrease
of the Bright Mean, whereas mutation of kB site II (mutII NF-kB)
Figure 2. Sp1 and kB Sites Regulate Off and Bright Dynamics. (A) Jurkat cells were infected with LGIT and corresponding Sp1 and kB mutants
at low MOI (,0.05–0.10) in biological triplicate (for WT LGIT and Sp1 mutants) or biological quadruplicate (for WT LGIT and kB mutants), and data are
the averages of these replicates at each day of the 21-day time course. Shown are the mean of the Bright peak positions (as illustrated in Figure 1C)
from the GFP histograms for all time points, as measured by flow cytometry in units of mean fluorescence intensity (MFI). The results from WT LGIT
control for two separate experiments (open square or triangle points) are shown together. Data for each mutant (solid circle points) are shown with
the corresponding WT LGIT control. Error bars are the standard deviation of the biological quadruplicate or triplicate measurements. Statistically
significant differences from WT LGIT are denoted by single asterisks (*, p,0.01). The steady state Bright Mean values at 10 days after infection are
shown within each panel. Two LGIT variants (mutALL Sp1 and mutIII Sp1/mutI NF-kB) failed to generate a GFP
+ population of cells after infection at low
MOI (,0.05–0.10) and were thus omitted from this study (see Figure S1B). Further details of data analyses are in available in Materials and Methods.
(B) The same experiment as in (A), but depicting the fraction of infected and GFP
+ cells persisting in the Mid region (Mid:On ratio), in which ‘‘On’’ is
the sum of ‘‘Mid’’ and ‘‘Bright’’ regions (Figure 1C), for the duration of the time course. Error bars are the standard deviation of the biological
quadruplicate or triplicate measurements. Statistically significant differences from WT LGIT are denoted by single asterisks (*, p,0.01). The ‘‘steady
state’’ Mid:On values at 10 days after infection are shown within each panel.
doi:10.1371/journal.ppat.1000260.g002
Sp1 and kB Sites Regulate HIV Latency
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after infection) increase of the Bright Mean (Figure 2A).
Interestingly, these results indicate that the roles of the two kB
sites in the HIV promoter are not redundant, with an intact site I
serving an activating role and site II a slightly repressing role.
Consistent with these observations, the double kB mutant (mutI&II
NF-kB) exhibited gene expression levels closer to those of the WT
promoter than mutI NF-kB, indicating that the loss of the
repressing site II slightly counteracts the loss of the activating site
I. In contrast to mutI&II NF-kB, del NF-kB exhibited a severe loss
in gene expression, indicating that the complete deletion of the 24
nucleotides encompassing the kB sites had effects beyond the loss
of NF-kB binding, perhaps through altered nucleosome spacing
[36] or loss of the NFAT1 and GABP transcription factor binding
sites at the 39 ends of the kB sites [52,53], which were not affected
by the individual mutations in mutI&II NF-kB. To focus analysis
specifically on the roles of kB recruitment, we did not pursue
analysis of the variant with full deletion of both kB sites.
In contrast to the Sp1 mutants, mutation of the kB sites had
modest effects on the Mid:On ratio compared to the WT LTR
(Figure 2B). However, significant differences between kB sites I
and II are evident, as mutII NF-kB had no change in the Mid:On
ratio, but mutI NF-kB exhibited a 1.5-fold increase compared to
the WT promoter. Thus, the observed decrease in the Bright
Mean position of mutI NF-kB (Figure 2A) is consistent with
destabilization of the Bright mode, resulting in noisier gene
expression or an increased Mid:On ratio (Figure 2B).
Promoter mutations increase the population of ‘‘Infected
but Off’’ cells
Infecting cells at an MOI of 0.05–0.10 results in approximately
90–95% of cells being uninfected (Figure 3A, panel 1) as predicted
by a Poisson distribution. However, a fraction of the infected cells
may conceivably persist in the Off mode and thus be indistin-
guishable from the uninfected cells by flow cytometry. This
fraction of ‘‘Infected but Off’’ cells provides additional insights into
the relative stability of the Off and Bright modes for the different
mutants. Specifically, increases in the fraction of Infected but Off
cells suggest an increase in the stability of the Off mode or a
decrease in the stability of the Bright mode, impeding cells from
undergoing Tat transactivation. To measure the fraction of
Infected but Off cells, we stimulated gene expression through
simultaneous addition of exogenous Tat [18] and the hybrid polar
compound hexamethylene bisacetamide (HMBA), which activates
HIV transcription independent of the NF-kB pathway [54]. Six
days after infection, cells were treated with 5 mM HMBA and Tat
protein (8 mg per 3610
5 cells) and incubated for 18 hours
(Figure 3A, panel 2). This combined stimulation increased the
fraction of the WT LGIT infected cells that expressed GFP by
17.0%60.8% of infected cells, which would otherwise persist in
the Off mode (Figure 3B).
Interestingly, all three Sp1 mutants exhibited considerably
higher fractions of Infected but Off cells, peaking with mutIII Sp1 at
57.6%63.7% (Figure 3B). In addition, mutation of kB site I (in
both mutI NF-kB and mutI&II NF-kB), but not kB site II, resulted
in a more modest but significant increase in the fraction of infected
cells being Off (Figure 3B). Specifically, mutII NF-kB is
indistinguishable from WT LGIT (p=0.64), but mutI NF-kB
exhibited statistically higher fractions of Infected but Off cells
(p,0.01). These are consistent with our observations that the two
kB sites are functionally different, with kB site I having a stronger
activating role (Figure 2A). Collectively, these data indicate that
loss of any of the Sp1 sites, and to a lesser degree kB site I,
destabilizes the Bright, transactivated expression state.
Mutation of Sp1 sites destabilizes both transactivated
(Bright) and latent (Off) gene expression modes
To examine the relative stabilities and switching dynamics of
the Bright and Off modes of expression, we sorted pure
populations of infected cells that had persisted in the Bright mode
(Bright sort, Figure 3A, panel 5) or relaxed into the Off mode (Off
sort, Figure 3A, panel 6). The polyclonal Bright and Off sorts are
phenotypically homogeneous populations of singly-integrated cells
that represent a wide range (.10
5) of integration positions. The
distribution of viral gene expression in Bright and Off modes was
dynamic, and the stability of the Bright mode of the bimodal
distribution of LGIT was determined by measuring the spontane-
ous inactivation or relaxation of Bright-sorted cells (Figure 3A,
panel 5). Fourteen days after sorting the Bright population, the
frequencies of spontaneous inactivation (%Loss of Bright) for each
of the three individual Sp1 mutations (mutI Sp1, mutII Sp1, and
mutIII Sp1) increased significantly compared to WT LGIT
(Figure 3C). Consistent with previous findings (Figures 2A and
3B), this trend again indicates that each Sp1 site may contribute to
the stability of the Bright mode. In contrast to the Sp1 mutants,
the frequencies of spontaneous inactivation for the kB site mutants
(mutI NF-kB and mutII NF-kB, and mutI&II NF-kB) were
unchanged compared to WT LGIT (Figure 3C, p=0.20 and
0.15, respectively), suggesting that the kB sites play a compara-
tively smaller role in the stability of the Bright mode.
To examine the stability of the Off mode we measured the
spontaneous initiation of GFP expression from the Off-sorted cells
(Figure 3A, panel 6), which we refer to as spontaneous activation.
After 28 days of culturing the Off-sorted cells for WT LGIT, fewer
than 3% of these cells activated out of the Off region (%Loss of
Off), which demonstrates the stability of its Off mode. However,
mutation of any of the three Sp1 sites resulted in dramatic
increases (2- to 3-fold) in the rates of spontaneous activation
compared to WT LGIT (Figure 3D), indicating that each of these
three mutants has a destabilized Off mode. This result implies that
in the Off state, Sp1 sites may be involved in a repressive
mechanism, such as recruitment of HDAC complexes by
individual Sp1 proteins [34,39,55]. This observation is surprising
in light of earlier results suggesting that each Sp1 site is required
for strong activation (Figure 3B and 3C). Each of the Sp1 sites may
thus serve a repressing role in the Off mode and an activating role
in the Bright mode, and the dynamic interplay between these roles
may contribute to transcriptional noise and stochastic switching.
Analysis of the Off mode also revealed a reduction in
spontaneous activation for mutI NF-kB and mutI&II NF-kB (by
approximately 30% and 50%, respectively) relative to WT
(Figure 3D), consistent with earlier observations that kB site I is
important for the recruitment of an activating complex (Figures 2A
and 3B). By contrast, kB site II did not affect spontaneous
activation, as LGIT and mutII NF-kB are statistically indistinguish-
able (Figure 3D, p=0.31), suggesting that in the Off state the
second kB site does not recruit the same activating complex as the
proximal site. Again, the roles of the two kB sites significantly
differ (as in Figures 2 and 3B), with kB site I exhibiting a greater
activating role than kB site II.
Promoter mutations increase the frequency of
phenotypic bifurcation
In addition to regulating the overall dynamics and steady states
of viral gene expression, the individual Sp1 and kB elements may
influence stochastic aspects of viral gene expression and thereby
affect viral latency. We hypothesized that the dynamic balance in
the recruitment of repressing and activating factors to individual
Sp1 and kB Sites Regulate HIV Latency
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Bright modes of gene expression, and mutation of these sites would
therefore impact the frequency of phenotypic bifurcation (PheB),
singly infected clonal cell populations that split into Off and Bright
gene expression modes [9].
To analyze the role of individual transcription factor binding
sites in the bifurcation phenotype, we isolated 362 individual
clones from WT and mutant LGIT populations. Six days after
infection, LGIT (and mutant) infected cells from Figure 2 were
transiently stimulated with HMBA/Tat, and the infected (On)
populations were isolated using fluorescence activated cell sorting
(FACS) (Figure 3A, panel 3). These polyclonal populations were
allowed to relax for one week, and single cells were then sorted
from the Mid region, expanded, and analyzed by flow cytometry
for heterogeneous expression and Phenotypic Bifurcation (PheB)
in gene expression levels (Figure 3A, panel 7).
The frequency of bifurcation for WT LGIT was 1.77%60.35%
(Figure 4A), a level consistent with our prior findings [9]. In
addition, all kB mutations yielded a PheB-clone frequency
statistically indistinguishable from WT LGIT. Strikingly, however,
all three Sp1 mutants exhibited a greater than 6-fold increase in
the frequency of PheB. These results are consistent with the
increased Mid:On ratio for Sp1 mutants (Figure 2B) and the
increased dynamic switching between Off and Bright sorts
(Figure 3C and 3D), and further indicate that the loss of any of
the three Sp1 sites increases stochastic flipping between Off and
Bright modes.
Mutation of any Sp1 site thus renders the viral promoter both
weakly silenced (Off) and weakly transactivated (Bright), resulting
in increased rates of spontaneous switching and phenotypic
bifurcation. In agreement with this interpretation, there are
compelling correlations between the frequency of PheB and the
fraction of spontaneous inactivation (Figure 4B) and spontaneous
activation (Figure 4C), indicating increased transcriptional noise
and stochastic switching between two ‘‘less stable’’ states
(Figure 1C). Together, these data reveal that each Sp1 site2and
particularly Sp1 site III2plays an important role in the control of
stochastic gene expression by regulating the active and inactive
gene expression states via the recruitment of activating and
repressing factors. This is the first demonstration that specific cis-
regulatory elements within the HIV promoter contribute to
transcriptional stochasticity and implicates the Sp1 sites as
significant factors in the establishment and maintenance of
proviral latency.
Figure 3. Sp1 Sites Regulate Fraction of Infected but Off Dynamic Switching. (A) Jurkat cells were infected with either LGIT, mutI Sp1, mutII
Sp1, mutIII Sp1, mutI NF-kB, mutII NF-kB,o rmutI&II NF-kB lentivirus at low MOI (,0.05-0.10) (panel 1). Six days post-infection, LGIT gene expression
was stimulated with HMBA and exogenous Tat protein (panel 2). Eighteen hours after stimulation, GFP+ cells were sorted with FACS to isolate
infected from uninfected cells (panel 3), and cells were then cultured under normal conditions for one week to allow relaxation of expression levels
(panel 4). After relaxing into Off and Bright peaks, FACS sorting was used to isolate the polyclonal Bright fraction (panel 5), the polyclonal Off fraction
(panel 6), and individual clones (panel 7). (B) Infected but Off cells persist in the Off state in unstimulated conditions. Cells infected with WT LGIT, mutI
Sp1, mutII Sp1, mutIII Sp1, mutI NF-kB, mutII NF-kB, and mutI&II NF-kB were stimulated with HMBA and exogenous Tat protein to determine the total
number of infected cells (Figure 3A, panel 2). Shown are the fractions of infected cells that persist in the Off state (%Infected but Off). These data are
calculated by the simple formula: %Off_infected=(12%On_unstimulated)/(%On_stimulated). All data are averages of biological triplicates, and error bars are
standard deviations. Statistically significant differences from WT LGIT are denoted by single asterisks (*, p,0.01). (C) Bright-sorted LGIT cells
spontaneously inactivate into the Off mode under normal culturing conditions. Bright-sorted populations (Figure 3A, panel 5) were cultured for 14
days after FACS sorting to quantify the stability of the Bright mode. As analyzed by flow cytometry, a fraction of Bright-sorted cells relaxed out of the
Bright mode, which is indicated by ‘‘Loss of %Bright.’’ Error bars are standard deviations of triplicate measurements. Statistically significant differences
from WT LGIT are denoted by single asterisks (*, p,0.01). (D) Off-sorted LGIT cells spontaneously activate into the Bright mode under normal
culturing conditions. Off-sorted populations (Figure 3A, panel 6) were cultured for 28 days after FACS sorting to quantify the stability of the Off mode.
As analyzed by flow cytometry, a fraction of Off-sorted cells activated from the Off mode, which is indicated by ‘‘Loss of %Off.’’ Error bars are standard
deviations of triplicate measurements, and statistically significant differences from WT LGIT are denoted by single asterisks (*, p,0.01).
doi:10.1371/journal.ppat.1000260.g003
Sp1 and kB Sites Regulate HIV Latency
PLoS Pathogens | www.plospathogens.org 6 January 2009 | Volume 5 | Issue 1 | e1000260Figure 4. Sp1 Sites Regulate Phenotypic Bifurcation and Transcriptional Dynamics. (A) Clonal populations phenotypically bifurcate (PheB)
into Off and Bright modes. Clonal FACS-sorting was performed to isolate single cells from LGIT, mutI Sp1, mutII Sp1, mutIII Sp1, mutI NF-kB, mutII NF-kB,
and mutI&II NF-kB infected populations (Figure 3A, panel 7). Each single cell was expanded as a clonal population to achieve least 10
6 cells and analyzed
by flow cytometry to measure GFP expression. PheB was defined as a clonal population having more than 0.5% of cells in each of the ‘‘Off’’ and ‘‘Bright’’
gates after four weeks of expansion in normal culturing conditions. In total, 362 LGIT and LGIT mutant clones were sorted, expanded, and analyzed. Of
these,190exhibitedPheBbehavior inGFPgeneexpression.Todetermine statisticalvarianceforeachmutant, qualification foreachclone(either PheB or
non-PheB) from each mutant were randomly placed into one of three bins, and the error bars represent the standard deviations for the three bins. (B)
Correlation of spontaneous inactivation (Figure 3C) and Phenotypic Bifurcation (A). Together, these data show the correlation between the stability of
theBright mode (Loss of %Bright) andthe degree of transcriptional noise(%PheB). (C)Correlationof spontaneous activation (Figure 3D)andPhenotypic
Bifurcation (A). Similarly to (B), these data show the correlation between the stability of the Off mode (Loss of %Off) and the degree of transcriptional
noise (%PheB). (D) Off and Bright fractions of one phenotypically bifurcating (PheB) clone from each LGIT variant were isolated with FACS (Figure S2).
Four days after sorting, Off and Bright sorts were analyzed by flow cytometry to measure the extent of dynamic switching. Each ‘‘normalized switching’’
value is the fraction of cells that have switched into the specified region divided by the fraction of cells in that region for the unsorted population. White
bars indicate the switching of Off sorts into the Bright region, and black bars indicate the switching of Bright sorts into the Off region. (E) The same asi n
(D)withflowcytometryanalysesperformedsevendaysafterFACSsorting.White bars indicatetheswitchingofOffsortsinto theBrightregion,andblack
bars indicate the switching of Bright sorts into the Off region. Histograms are provided in Figure S2.
doi:10.1371/journal.ppat.1000260.g004
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LGIT mutant
To further support our hypothesis that the Sp1 mutants have
increased switching dynamics, we have examined the switching
dynamics of Off and Bright sorts of PheB clones for the LGIT
variants (Figure S2). We hypothesize that the clonal Off and Bright
sorts may exhibit switching dynamics similar to the polyclonal
populations (Figure 3C and 3D) and may partially converge back
to the original bimodal distribution. Due to the rarity of clonal
populations exhibiting PheB for all LGIT variants (,2%–15%
depending on mutant, Figure 4A)—and since gene expression
profiles widely vary between different PheB clones—isolating and
identifying different PheB clones that have identical gene
expression profiles was not possible. However, we selected one
PheB clone for each LGIT mutant that exhibited similar
bimodality and isolated the Bright and Off modes using FACS
(Figure S2). We have normalized the measured switching effects by
the distribution from the unsorted clone, and the resulting
‘‘normalized switching’’ value provides a metric for the conver-
gence to the original bimodal distribution. Values ranging from
zero (no switching) to one (complete convergence) enable the
evaluation of clonal switching dynamics for each Sp1 or kB
mutant.
At four and seven days after FACS sorting, we have measured
the GFP distributions for the unsorted, Off-sorted, and Bright-
sorted fractions (Figure S2). The Bright fractions for each Sp1
mutant clone (S1.C1, S2. A3, and S3.B6) exhibit increased
switching into the Off region (Figure 4D and 4E), which mimic
increased spontaneous inactivation in polyclonal Bright sorts
(Figure 3C). Similarly, Off-sorted fractions from the clones for
mutII Sp1 (S2.A3) and mutIII Sp1 (S3.B6) have dramatically
enhanced switching into the Bright region seven days after sorting
(Figure 4E), which are consistent with spontaneous activation of
the polyclonal Off sorts (Figure 3D). In contrast, the Off-sorted
fraction from the clone for mutI NF-kB (N1.D5) exhibits decreased
switching into the Bright region (Figure 4D and 4E), consistent
with the observed polyclonal dynamics that this mutant has a
stabilized Off mode (Figure 3D). Collectively, clonal and
polyclonal switching dynamics reveal destabilization of the Off
and Bright modes for the Sp1 mutants (Figure 3C and 3D).
mutIII Sp1 is desensitized to TSA and mutI NF-kB is
resistant to TNF-a induction
To identify mechanistic differences in the roles of individual Sp1
and kB sites, we performed exogenous perturbations on each
LGIT variant. Two weeks after infection with LGIT or mutants (the
same unsorted populations analyzed in Figures 2 and 3A, panel 1),
cells were stimulated with TNF-a (20 ng/ml) or TSA (400 nM) for
18 hours. The change in Bright Mean after perturbation revealed
differential contributions for each site in the Bright mode
(histograms in Figure S1B and non-normalized data in Table S4).
Although each of the three Sp1 mutants exhibited a lower
Bright Mean than WT (Figure 2A), stimulation with TNF-a
strongly increased the Bright Mean position of mutI Sp1, mutII Sp1,
and mutIII Sp1 (Figure 5A, gray bars), confirming that these
promoters are susceptible to activation via NF-kB dependent
pathways. Furthermore, stimulation with the HDAC inhibitor
TSA increased the Bright Mean almost 2-fold in mutI Sp1 and
mutII Sp1 (Figure 5A, black bars). Since Sp1 has been shown to
recruit class I HDACs to the HIV promoter [39], TSA inhibition
of these HDACs may shift the chromatin modification balance
towards acetylation by HATs. However, mutIII Sp1 was strikingly
insensitive to TSA (Figure 5A), suggesting that this mutant may
have minor regulation by HDACs or that it may not have
sufficient HAT occupancy to take advantage of HDAC inhibition.
Of these two possibilities, the former is consistent with a
destabilized Off mode (Figures 3D and 4C), while the latter is
consistent with a destabilized Bright mode (Figures 3C and 4B).
Both mutI NF-kB and mutII NF-kB were activated by TNF-a,
though to a lesser extent than the WT promoter. However, mutI
NF-kB was slightly but significantly less activated than mutII NF-kB
(p,0.05), consistent with our prior findings that mutI NF-kB has
lower levels of gene expression than mutII NF-kB (Figure 2A).
TNF-a induced no relative change in the Bright Mean position for
mutI&II NF-kB, confirming that this double mutation eliminated
NF-kB-mediated activation of the HIV promoter (Figure 5A, gray
bars). Stimulation with TSA strongly increased the Bright Mean
position for all kB mutants, including mutI&II NF-kB, as its effects
are not dependent upon NF-kB activation (Figure 5A, black bars).
However, in contrast to TNF-a, TSA activated mutI NF-kB more
strongly than mutII NF-kB or WT (p,0.05), suggesting that mutI
NF-kB may be more heavily repressed by class I HDACs.
Figure 5. Perturbations of Sp1 and kB Mutants. (A) Stimulation
with TNF-a or TSA increases the Bright Mean. Unsorted populations
infected with LGIT, mutI Sp1, mutII Sp1, mutIII Sp1, mutI NF-kB, mutII NF-
kB, and mutI&II NF-kB (same as in Figure 2) were stimulated with TNF-a
(gray bars) or TSA (black bars) two weeks after infection. The Bright
Mean position of stimulated cells and control (unperturbed) cells was
measured by flow cytometry 18 hours after stimulation. Notably, no
significant change in the Bright Mean was observed for mutI&II NF-kB
upon TNF-a stimulation, confirming that the kB mutations abrogate NF-
kB-mediated activation. The Normalized Bright Mean for LGIT and all
LGIT variants was normalized by the unstimulated Bright Mean for each
corresponding variant (see Figure 2A). Raw data for these measure-
ments are provided in Table S4. All data are averages of biological
triplicates, and error bars are standard deviations. Histograms of these
perturbations are presented in Figure S1B. Statistically significant
differences from WT LGIT are denoted by single asterisks (*, p,0.01)
and double asterisks (**, p,0.05). (B) Stimulation with TNF-a or TSA
activates the infected cells that persist in the Off state in unstimulated
conditions. Cells were prepared to isolate the fraction of ‘‘Infected but
Off’’ cells by serial FACS sorting (Figure 3A, panel 6). At day 17 post-
infection and three days after FACS sorting from the Off region, cells
were stimulated with TNF-a or TSA. The data are the fraction of Off-
sorted cells that activate into the On region after stimulation. Flow
cytometry measurements were performed 18 hours after stimulation.
All data are averages of biological triplicates, and error bars are
standard deviations. Statistically significant differences from WT LGIT are
denoted by single asterisks (*, p,0.01).
doi:10.1371/journal.ppat.1000260.g005
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Using the Off-sorted polyclonal populations (Figure 3A, panel 6)
as a model for HIV latency, we examined the stability of the Off
mode by measuring the susceptibility of Off-sorted cells to
activation by TNF-a and TSA. TNF-a activated approximately
33% of the Off-sorted LGIT cells, demonstrating that a large
fraction of these ‘‘latent’’ cells is capable of reactivation via a NF-
kB-dependent mechanism (Figure 5B, gray bars). Each of the Off-
sorted Sp1 mutants responded more strongly to TNF-a induction
than WT LGIT (Figure 5B). These results are consistent with the
previously observed increase in Bright Mean position for these
mutants (Figure 5A), suggesting that these mutants are deficient in
recruiting RelA under unstimulated conditions.
TSA activates approximately 35% of the Off-sorted, ‘‘latent’’
cellsofthemutISp1andmutII Sp1populations(Figure5B,blackbars)
but only 13% of mutIII Sp1 cells, analogous to results in unsorted
cells (Figure 5A, black bars). These results suggest that all these
mutants are repressed by HDACs in the Off state, but that Sp1 site
III is specifically required for an effective response to TSA, possibly
because it plays a key role in recruitment of HAT complexes.
In contrast to WT LGIT and the corresponding Sp1 mutants, in
which at least one-third of the Off cells were activated by TNF-a,
both mutI NF-kB and mutI&II NF-kB were virtually insensitive to
TNF-a stimulation, indicating that kB site I is essential for NF-kB-
dependent activation of Off cells (Figure 5B, gray bars). However,
13%ofmutIINF-kBcellsrespondedtoTNF-astimulation(Figure5B),
further demonstrating that when intact, this kB site plays a significant,
but weaker, role in NF-kB activation than site I. Finally, all three kB
mutants exhibited reduced responses to TSA stimulation compared
to WT LGIT (Figure 5B, black bars), suggesting that both kBs i t e s
have significant but unequal roles in the recruitment of p50-p50
homodimer and HDAC complexes in the latent state.
Chromatin immunoprecipitation on Off- and Bright-
sorted polyclonal populations
The gene expression and perturbation results thus far suggest that
individual Sp1 binding sites differentially recruit activating and
repressing transcription factors, thereby differentially stabilizing the
Off and Bright expression modes and contributing to gene expression
noise (Figure 4B and 4C). We used chromatin immunoprecipitation
(ChIP) to measure p50, RelA, p300, Sp1, and HDAC1 protein
occupancy at the LTR in populations sorted from Off (Figure 3A,
panel 6) and Bright (Figure 3A, panel 5) regions. Additionally, we
have analyzed Off and Bright sorts for acetylation of lysines 9 and 14
of the tail of histone 3 (AcH3, markers for active chromatin [54]) and
trimethylation of lysine 9 (TriMetH3K9, a signature of repressed
chromatin [56]). Performing ChIP on Off- and Bright-sorted
populations is distinct from recent ChIP analyses on chromatin
targets of transfected and/or integrated LTR, which used pharma-
cological factors including TNF-a, TSA, and phorbol esters to
observe occupancy and histone acetylation patterns in the stimulated
or unstimulated wild type LTR [3,32,46,47,57,58]. Our work focuses
instead on analyzing differences in the occupancies of chromatin
regulators and transcription factors within Off and Bright modes of
integrated viral mutants in unstimulated conditions. Such quantita-
tive differences in LTR occupancy between two coexisting cell
populations may influence and reflect the fate of the provirus towards
transcriptional activation or repression and latency.
Recruitment of RelA in the Off mode is mediated by kB
site I and Sp1 site III
ChIP analysis revealed that RelA recruitment to the HIV
promoter in Off-sorted cells was reduced approximately 10-fold
for mutIII Sp1 as compared to WT (Figure 6B). In contrast, mutI
Sp1 and mutII Sp1 promoters recruit RelA to similar extents as WT
in both the Off and Bright populations (Figure 6B, p.0.20
compared to respective WT sorts). This finding is consistent with
gene expression results suggesting that Sp1 site III is important for
recruiting activating complexes, as its mutation led to a higher
fraction of Infected but Off cells (Figure 3B), as well as insensitivity
to TSA (Figure 5). Therefore, we conclude that Sp1 site III
enhances the ability of the kB sites to recruit RelA, and
destabilization of the Bright mode in mutIII Sp1 may in part be
due to insufficient recruitment of RelA.
ChIP on mutI NF-kB revealed that recruitment of RelA
decreased approximately 3-fold for mutI NF-kB as compared to
WT but was unchanged for mutII NF-kB (Figure 6B), confirming
distinct roles for the two sites. Also, WT LGIT, mutI NF-kB, and
mutII NF-kB recruit RelA to similar extents in the Bright sort
(Figure 6B), indicating that kB site I in particular is necessary for
the recruitment of p50-RelA heterodimer in the Off mode, but
that both kB sites can sufficiently recruit the heterodimer in the
Bright mode. ChIP for p50 indicated that WT LGIT, mutI NF-kB,
and mutII NF-kB variants recruit p50 to similar extents (Figure
S3A), consistent with the fact that p50 is present as part of both the
p50-p50 homodimer and the p50-RelA heterodimer (Figure S3B).
Thus, ChIP data strongly support the prior hypothesis that kB site
I recruits RelA to a greater extent than site II in the Off mode
(Figure S3C and S3D). Collectively, our results demonstrate that
the two kB sites have distinct roles in transcriptional regulation,
and implicate unequal roles in the establishment and maintenance
of latency.
Recruitment of p300 in the Off mode is mediated by Sp1
site III
Histone acetyltransferase p300 is a central factor in HIV
transactivation [30] that is actively recruited to the HIV promoter
[24] by Sp1 [59] and NF-kB [28,60] complexes. Analysis of p300
by ChIP revealed similar levels of recruitment for all Bright
populations (Figure 6C). However, we observed a ten-fold
reduction in p300 recruitment for mutIII Sp1 relative to mutI Sp1,
mutII Sp1, and WT in the Off-sorted populations, indicating that
Sp1 site III is particularly important for recruiting p300 to the
HIV promoter in the Off or latent state. Since mutIII Sp1 suffers a
loss of p300 recruitment in the Off mode, the striking insensitivity
to TSA stimulation for this mutant (Figure 5) is likely due to the
inability to recruit this HAT after inhibition of HDAC activity.
We next analyzed the overall recruitment of Sp1 protein to each
LTR in Off and Bright populations. In the Off fraction, the WT
promoter and each of the individual Sp1 mutant promoters recruit
Sp1 to similar extents (Figure 6D). However, in the Bright fractions,
mutation of any of the Sp1 sites results in greater than 10-fold
reduction in Sp1 recruitment. This loss of Sp1 in the transactivated
(Bright) mode does not correlate with loss of p300 (Figure 6C),
suggesting that other factors, including RelA [28,60] and Tat
protein [30,61], may be involved in the localization of p300.
Recruitment of HDAC1 in the Off mode is regulated by
Sp1 site III
Transcriptional repression is commonly regulated by histone
deacetylation, and HDAC1 is associated with p50-p50 homodimer
[3] and Sp1 [39] at the HIV-1 LTR. Therefore, we performed
ChIP against HDAC1 to determine its recruitment to each Sp1
and kB site and its role in transcriptional repression (Off sorts) vs.
activation (Bright sorts). ChIP on the Off sorts revealed statistical
decreases in HDAC1 occupancy for all mutants, except mutI NF-
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PLoS Pathogens | www.plospathogens.org 9 January 2009 | Volume 5 | Issue 1 | e1000260Figure 6. Occupancy of Sp1 and kB Sites in Bright and Off States. (A) Flow cytometry histograms of expanded populations of Off- and Bright-
sorted Jurkats infected with LGIT and each LGIT mutant (as in Figure 3A, panels 5–6). 10
6 cells were initially sorted from Off and Bright regions, and
seven days of expansion was conducted to achieve 5610
7 cells necessary for this ChIP protocol. We observed a moderate extent of BrightROff and
OffRBright dynamic switching over this one-week expansion. (B) RelA ChIP results for Off- and Bright-sorted populations of LGIT, mutI Sp1, mutII Sp1,
mutIII Sp1, mutI NF-kB, and mutII NF-kB. Immunoprecipitations were performed using RelA antibody, and immunoprecipitated DNA was quantified
using QPCR with primers against the HIV LTR. For analysis of input DNA and RelA immunoprecipitation, all LTR QPCR measurements were normalized
by with ChIP-QPCR measurements for the endogenous TAP1/LMP2 regulatory domain [86], which contains single kB and Sp1 sites that recruit RelA
and p50 (refer to Figure S4A and S4B for non-normalized results). Primer sequences and QPCR conditions for HIV LTR and TAP1/LMP2 are supplied in
Materials and Methods and Table S2. The QPCR measurements for LTR and control TAP1/LMP2 were performed in triplicate, and error bars are
standard deviations. Statistically significant differences from WT LGIT are denoted by black single asterisks (*, p,0.05), and significant differences
between the Off and Bright sorts for any particular mutant is denoted by gray double asterisks (**, p,0.05). (C) p300 ChIP results for Off- and Bright-
sorted populations of LGIT, mutI Sp1, mutII Sp1, mutIII Sp1, mutI NF-kB, and mutII NF-kB. Immunoprecipitations were performed using a p300
antibody, and QPCR measurements were normalized by the endogenous BCL2L1 regulatory domain [87], which contains Sp1 elements and has been
shown to recruit p300 and Sp1 (refer to Figure S4C for non-normalized results). The QPCR measurements for LTR and control BCL2L1 were performed
in triplicate, and error bars are standard deviations. Statistics analyses are the same as in (B). (D) The same experiments as in (C) with a Sp1 antibody.
Off- and Bright-sorted populations of LGIT, mutI Sp1, mutII Sp1, mutIII Sp1, and mutI NF-kB were examined for the presence of Sp1, and QPCR
measurements were normalized by the BCL2L1 regulatory domain (refer to Figure S4D for non-normalized results). mutII NF-kB was not performed, as
denoted by ‘‘NP.’’ Statistics analyses are the same as in (B). (E) HDAC1 ChIP results for Off- and Bright-sorted populations of LGIT, mutI Sp1, mutII Sp1,
mutIII Sp1, mutI NF-kB, and mutII NF-kB. QPCR measurements were normalized by the input DNA. Statistics are the same as in (B). (F) Acetylated
histone 3 (lysines 9 and 14) for Off- and Bright-sorted populations of LGIT, mutI Sp1, mutII Sp1, mutIII Sp1, mutI NF-kB, and mutII NF-kB. Total histone 3
(H3) was also quantified by ChIP, and the presented data are the ratios of these QPCR measurements (AcH3/H3). Statistics are the same as in (B). (G)
Real time RT-PCR analysis on initiated and fully elongated transcripts for Off-sorted LGIT, mutIII Sp1, mutI NF-kB, and mutII NF-kB cell populations. Off
sorts were performed as in Figure 6A, and cells were expanded for approximately one week before mRNA extraction. Details for mRNA preparation
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HDAC1 occupancy in the Bright sorts was statistically indistin-
guishable from WT for all mutants (p.0.1, Figure 6E). Addition-
ally, WT and all mutants except mutIII Sp1 had elevated levels of
HDAC1 occupancy in the Off sorts compared to the respective
Bright sorts (p,0.1, Figure 6E). Collectively, these ChIP findings
reveal that each Sp1 site and kB site II are important in the
recruitment of HDAC1, and that mutation of Sp1 site III abolishes
differential regulation of HDAC1 between Off and Bright modes.
All Sp1 and kB elements are required for maximum
acetylation of H3
To estimate differences in overall levels of transcriptional
activation between Off and Bright sorts and between WT and
mutant populations, we measured acetylation of the histone 3 tail
at lysines 9 and 14 (AcH3) by ChIP and normalized to total
histone 3 (Figure 6F). In the Off sort, each mutant was statistically
indistinguishable to WT LGIT (p.0.05, Figure 6F). In contrast,
the Bright sorts revealed significant decreases of AcH3 for all
mutants compared to WT. These results show that each Sp1 and
kB site is essential for maximum acetylation of H3. However, there
are no significant differences in AcH3 between Off and Bright
sorts of mutI Sp1, mutII Sp1, and mutIII Sp1 cells, indicating that
each of the three Sp1 sites is required for the regulation of the
deacetylated (Off) and acetylated (Bright) states.
Lastly, to examine an indicator of repressed chromatin beyond
histone deacetylation, we performed ChIP for Off and Bright sorts
to examine trimethylation of histone 3 at lysine 9 (TriMetH3K9).
However, we observed undetectable levels of TriMetH3 for the
Off and Bright sorts of WT LGIT and all Sp1 and kB mutants
(Figure S4E), suggesting that trimethylation of H3K9 is not a
significant factor in the phenotypes we observe in LGIT, including
dynamic switching and stabilization of the Off mode.
Reduction of RelA recruitment decreases transcriptional
initiation and elongation
Sp1 site III regulates recruitment of repressor HDAC1
(Figure 6E) and activators p300 (Figure 6C) and p50-RelA
(Figure 6B). In contrast, RelA occupancy is not hindered by
mutation of kB site II; however, mutation of kB site I decreases the
occupancy of p50-RelA heterodimer but apparently not p50-p50
homodimer (Figure 6B and Figure S3C and S3D). The differences
in p50-p50, p50-RelA, p300, and HDAC1 occupancies at these
mutant promoters likely influence the frequencies of both
transcription initiation and elongation at the LTR. In particular,
an inactive LTR occupied with a repressive p50-p50 homodimer
and HDAC1 would be unable to recruit RNAPII and would thus
not initiate transcription [3]. In contrast, when p50-RelA
heterodimer and p300 localize to the LTR, RNAPII is readily
recruited and phosphorylated by P-TEFb, to generate fully
elongated, productive transcripts [3,19]. Competition between
the recruitment of repressing p50-RelA heterodimer and p50-p50
homodimer may result in RNAPII initiating transcription and
then stalling, which results in a large number of abortive
transcripts and little GFP and Tat expression [3,19]. Thus, we
adapted a previously established RT-PCR method [3] to quantify
the functional differences transcriptional initiation and elongation
for the Off and Bright sorts of WT LGIT, mutIII Sp1, mutI NF-kB
and mutII NF-kB.
The Off sorts for mutI NF-kB and mutIII Sp1 have respective
decreases of 36% and 48% in the number of initiated transcripts
compared to WT (Figure 6G), in agreement with ChIP
observations that these two mutants have decreased p50-RelA
occupancy and potentially increased recruitment of the repressing
p50-p50 homodimer (Figures 6B and S3C). In contrast, there is no
statistical change in transcriptional initiation for the mutII NF-kB
Off sort (p=0.88 vs. WT, Figure 6G), also in agreement with
ChIP observations of no change in p50-RelA occupancy vs. WT
(Figure 6B). Quantification of transcriptional initiation on Bright-
sorted populations revealed a similar trend, in which mutII NF-kB
exhibited a 35% increase in the number of initiated transcripts
compared to WT, while mutI NF-kB and mutIII Sp1 have
significant decreases (18% and 63%, respectively, Figure 6F).
Although transcription initiation was not hindered for mutII NF-
kB (and was actually enhanced in the Bright mode), this mutant
has a 48% decrease in the number of elongated transcripts vs. WT
in the Off sort and a 15% decrease in the Bright sort (Figure 6E
and 6F). Mutation of kB site I further decreased transcriptional
elongation, with 57% and 38% decreases for Off and Bright sorts
vs. WT, respectively (Figure 6E and 6F). These findings
demonstrate that while both kB sites are required for full
transcriptional elongation, kB site I has a greater contribution in
both transcriptional initiation and elongation. Importantly,
mutation of Sp1 site III has striking reduction of transcriptional
elongation in the Off and Bright modes (53% and 70% decreases,
respectively, Figure 6E and 6F), consistent with ChIP observations
that Sp1 site III is necessary for recruitment of RelA in both Off
and Bright modes and of p300 in the Off mode (Figure 6B).
Moreover, these data indicate that kB site I and Sp1 site III
combine to activate transcriptional initiation (likely in part via
recruitment of p50-RelA heterodimer), and mutation of either site
abrogates this role.
Summary of molecular and transcriptional phenotypes
Collectively, the molecular and transcriptional phenotypes
reveal that mutation of any Sp1 site destabilizes the Off and
Bright gene expression modes and increases dynamic switching
and phenotypic bifurcation. Alternatively, mutation of kB site I
appears to slightly increase the stability of the Off mode, while
mutation of kB site II may slightly stabilize the Bright mode. The
molecular regulation of Off and Bright modes of each LGIT
variant is summarized in Figure 7, which integrates the results
from ChIP, perturbation, and transcriptional experiments into a
model of transcription factor occupancies.
In Figure 7, the degree of shading (or transparency) of the
individual molecules corresponds to hypothetical degrees of
occupancy. For this study, these configurations are inferred by
functional tests (transcriptional activities and responses to
perturbation) and directly measured by ChIP, which are all
summarized in Figure S6. We hypothesize that repressing markers,
including p50-p50 homodimer, HDAC1, and deacetylation of
lysines 9 and 14 of histone 3 (H3K9/14), indicate a stabilized Off
mode and inactive transcription. In contrast, we hypothesize that a
stabilized Bright mode and transcriptional activation are charac-
QPCR are in Materials and Methods and calculations of measurements are discussed in Figure S5. Initiated transcripts were detected with primers for
TAR, and elongated transcripts were detected with primers for Tat. Since mutI Sp1 and mutII Sp1 did not suggest altered occupancy of p50-RelA
heterodimer or p50-p50 homodimer from ChIP experiments, these were not performed. Statistically significant differences from WT LGIT are denoted
by single asterisks (*, p,0.01). (H) The same experiments as in (G) performed on Bright-sorted LGIT, mutIII Sp1, mutI NF-kB, and mutII NF-kB. Bright
sorts were performed as in Figure 6A.
doi:10.1371/journal.ppat.1000260.g006
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of H3K9/14. However, the association of Sp1 with HDAC1 or
p300 may govern its structural conformation and DNA-binding
affinity [35,55,62], and we have illustrated these two conforma-
tions by the orientation of the Sp1 molecule (trapezoid). The
strongest destabilizing phenotypes occur with mutIII Sp1, which
displays the highest population of Infected but Off cells, highest
Mid:On ratio, and lowest Bright Mean position; exhibits the
strongest response to TNF-a but the weakest to TSA; yields the
highest frequency of phenotypic bifurcation and greatest dynamic
switching; and recruits decreased levels of RelA (Off mode), p300
(Off mode), HDAC1 (Off mode) and Sp1 (Bright mode) (Figures 7
and S6).
Discussion
We have previously demonstrated that stochastic fluctuations in
Tat levels may contribute to HIV-1 proviral latency by delaying
the onset of viral gene expression and Tat feedback [9]. In this
study, we explored how each Sp1 and kB element in the HIV
LTR modulates these stochastic fluctuations via differential
recruitment of activating and repressing factors. We found that
each Sp1 and kB site contributes distinctly to the dynamics of
switching between low and high gene expression modes and the
frequency of phenotypic bifurcation—both of which have
implications for viral latency.
This experimental system, based on single integrations of the
LGIT provirus in CD4
+ Jurkat cells [9], is similar in design to the J-
Lat model—a clonal Jurkat cell line with a single integration of
full-length HIV in which the viral gene Nef has been replaced by
GFP—which has been used as an in vitro model for HIV latency
[3,32,46,63]. In this study, individual Sp1 and kB elements within
the LTR of LGIT were disabled to dissect their contributions to
transcriptional activation and repression. Furthermore, this system
examines the dynamic behavior of single integrated proviruses
rather than transient transfection reporter systems [40–42]—
which provide valuable gene expression information but do not
account for the integration site, chromatin environment, and low
copy number of the provirus—or viral replication assays [43–
45]—which measure replicative fitness but not gene expression or
proviral latency. Additionally, by isolating and characterizing
transactivated (Bright) and latent (Off) populations, we examine
the contribution of each Sp1 and kB site to transactivated and
‘‘latent’’ states, as well as their responses to stimulation with
pharmacological agents TNF-a and TSA.
Gene expression results (Figures 2–4) provide corroborating
evidence that mutation of any o n eo ft h et h r e eS p 1b i n d i n gs i t e s
dramatically increases promoter sensitivity to transcriptional noise
and stochastic effects in the Tat feedback loop. Moreover, we
conclude that each Sp1 site—particularly Sp1 site III—plays an
important role in the control of stochastic gene expression by
stabilizing the inactive and active transcription states via the
Figure 7. Model of Sp1 and kB Occupancy in Off, Bright, and Intermediate Regions. This cartoon model proposes the localization of
chromatin factors to the Sp1 and kB sites within the HIV-1 LTR. The NF-kB dimers (p50-p50 or p50-RelA) lead to differential recruitment of HDAC1 or
p300, respectively. Likewise, the Sp1 protein has been demonstrated to recruit either activating HATs (such as p300) or repressing HDACs (such as
HDAC1). The structural conformation and association with either HDAC1 or p300 may govern the DNA-binding affinity of Sp1, and we have illustrated
these two conformations by the orientation of the Sp1 molecule (maroon trapezoid). Other symbols include p300 (orange triangle), RelA (blue
parallelogram), p50 (green rhombus), and HDAC1 (gray hexagon). The localization of repressing factors (illustrated below Sp1 and kB elements) is
enhanced in the Off mode and the presences of activating factors (above Sp1 and kB elements) is enhanced in the Bright mode. Note that kB site I
and Sp1 site III recruit RelA and p300, respectively, and these two sites appear to have an important synergistic and/or cooperative role in
transcriptional activation.
doi:10.1371/journal.ppat.1000260.g007
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In support of a destabilized Bright state, single Sp1 mutations and in
particular site III mutation result in a significantly weaker promoter
(Figure 2A), a 2- to 3-fold increase in the Off (latent) population of
infected cells (Figure 3B), rapid switching from Bright to Off
(Figure 3C), and a considerable loss of overall Sp1 binding to the
promoter in the Bright state as measured by ChIP (Figure 6D). As
support for a destabilized Off state, Sp1 mutations result in rapid
switching from Off to Bright (Figure 3D), a considerable increase in
the fraction of integrated provirus that responds to TNF-a (Figure 5),
and a decrease in the LTR occupancy of HDAC1 as measured by
ChIP (Figure 6E). In addition, as evidence of both destabilized Off
and Bright modes for the Sp1 mutants, there were insignificant
differences between the deacetylated vs. acetylated states of the
respective Off and Bright sorts (Figure 6E). Collectively, these
destabilizing effects result in a promoter more susceptible to
transcriptional noise and phenotypic bifurcation (Figure 4A), with
potentially important implications for viral latency.
We also demonstrate that the two kB sites, despite having identical
sequences, provide distinct roles in transcriptional activation. kBs i t eI
plays a preferential role in promoter activation, likely because
cooperativity between kB site I and the adjacent Sp1 site III promotes
recruitment of p50-RelA and p300 (Figure 6B and 6C). In contrast,
the distal kB site II provides a bias for the recruitment of p50-p50
homodimer (Figure S3C) and HDAC1 (Figure 6E). These observa-
tions bear similarities to TLR-induced genes in dendritic cells, in
which subunit specificities of kB sites are governed by cooperative
interactions with other factors, including CBP [64].
Binding cooperativity between Sp1 and RelA has been reported
in biochemical studies [65,66], and the distinct roles we have
observed for the different Sp1 and kB binding sites raises the
possibility that the individual enhancer sites may differentially
contribute to this cooperativity. ChIP results show that p300
recruitment to the mutI NF-kB promoter is maintained, whereas
RelA is lost; however, both p300 and RelA are lost in mutIII Sp1
(Figure 6B and 6C). This result implies that Sp1 site III may first
recruit p300, whose presence enhances p50-RelA localization to
kB site I. The proximity of kB site I to Sp1 site III may even
underlie its biased recruitment of the p50-RelA heterodimer,
which may be related to reported direct binding between RelA
and Sp1 [67] or between RelA and p300 [28,29].
Although Sp1 site III is required for p300 recruitment in the Off
mode, other factors at the LTR may contribute to subsequent
p300 maintenance at the promoter [35]. These may include p300
interacting with RelA [68], LEF-1 [38], YY1 [69], and SWI/SNF
[25,60], as well as p300 directly binding to DNA at motifs (i.e.,
GGGANT) found within the LTR, including in both kB elements
[70]. RelA and p300 are bound to the LTR in all Bright sorts, and
also in most Off sorts, supporting earlier models that RelA and
p300 are necessary, but not sufficient, for Tat-transactivation, and
recruitment of other factors (RNAP II, P-TEFb, PCAF, etc.) is
required [31,71]. Other potential factors contributing to RelA
localization at the promoter in the Off mode include its binding to
an inactive promoter [72], its potential interaction with various
HDACs [71,73,74], or the competing repressive roles of other
regulatory factors (YY1, LSF/LBP-1, etc.) [75–77].
Sp1 recruitment to WT LGIT was unchanged in Off vs. Bright
cells, as assessed by ChIP (Figure 6D). This finding corroborates a
recent study in transiently transfected cells that detected no change
in Sp1 levels at the LTR with or without addition of exogenous
Tat [58]. In contrast to the WT LTR, Sp1 recruitment to the Sp1
mutant promoters was compromised in the Bright sorts relative to
the Off sorts, potentially due to different Sp1 binding affinities in
the two expression modes. In the Bright sorts, the association of
individual Sp1 molecules with p300 may weaken its binding
affinity for DNA [35,62]. In contrast, Sp1 interactions with
HDAC1 appear to have no reduction in DNA binding [55]. The
DNA binding affinities of Sp1 are increased by homomultimeriza-
tion and synergy between Sp1 molecules [67,78], and Sp1 EMSA
analyses with the HIV-1 LTR have revealed that mutation of one
of the three Sp1 sites reduced Sp1 recruitment, while mutation of
two sites eliminated detection of Sp1 [79]. Thus, we hypothesize
that the diminished Sp1 levels in Bright sorts of Sp1 mutants may
result from decreased affinities of individual Sp1 molecules and
failure to recruit multimerized Sp1 complexes.
Collectively, these findings demonstrate that the balance
between the repressing and activating roles of each Sp1 site
impacts transcriptional noise and the propensity for latent
infections. Therefore, it appears that by recruiting activating and
repressing host factors, intact Sp1 sites dampen noise in HIV gene
expression. Although it remains to be determined whether such
noise arises from events external to (extrinsic) or directly from
(intrinsic) the mechanisms under study here [80], the Sp1 sites’
regulation of promoter activity and chromatin dynamics agrees
with a paradigm that eukaryotic promoters generate noise by
localization of chromatin factors [12,13]. Such local chromatin
dynamics may yield transcriptional pulses [16,17] that would be
amplified by Tat feedback.
Although the Sp1 and kB sites enhance replicative fitness of the
virus [43–45,50], variations and mutations within these sites are
often observed in isolates from subtype B cohorts [79,81,82].
Moreover, there is considerable sequence variability of Sp1 and
kB elements across different HIV-1 subtypes [82,83]. In addition
to altering the replication fitness of the virus, our findings suggest
that such evolutionary divergence within subtype B variants and
across other subtypes likely impact viral transcriptional dynamics
and propensities for latency. Thus, we postulate that variations in
promoter architectures will have important unexplored epidemi-
ological and therapeutic implications.
This work demonstrates the power of quantitative, dynamic
phenotyping of viral mutants for dissecting regulatory inputs into
the viral promoter in a proviral model of HIV. This approach
revealed that each Sp1 site influences the control of stochastic gene
expression by stabilizing both the active state—therefore likely
playing a role in the regulation of bursts in viral gene expression—
and the inactive state—thus playing a role in the establishment
and maintenance of proviral latency. It remains to be determined
which of these features are central to survival and propagation of
the virus in a natural environment or under therapeutic challenge.
Finally, this work may aid the future development of paradigms to
predict the gene expression and latency phenotypes of HIV-1
isolates and subtypes, as well as draw important correlations
between viral genotype and clinical outcomes and responses to
antiviral therapies.
Materials and Methods
Plasmids
Construction of LGIT plasmids has been previously described
[9]. Double and triple point mutations at the Sp1 and kB sites in
the HIV LTR were performed using the Quikchange PCR
method (Stratagene). The specific inactivating mutations used for
kB [50] and Sp1 [43,48,49] were previously described, and primer
sequences are listed in Table S1.
Cell culture and chemical perturbations
Jurkat cells were cultured in RPMI 1640 (Mediatech) medium
supplemented with 10% fetal bovine serum, 100 U/ml penicillin-
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concentrations between 2610
5 and 10
6 cells/ml in 5% CO2 at
37
oC. HEK 293T cells, used for lentiviral packaging, were
cultured in the same conditions as Jurkats but with Isocove’s
DMEM (Mediatech). For perturbation and viral titering experi-
ments, the following factors were used in the specified concentra-
tions: 20 ng/ml tumor necrosis factor-a (TNF-a, Sigma-Aldrich),
400 nM trichostatin A (TSA, Sigma-Aldrich), and 5 mM
hexamethylene bisacetamide (HMBA, Sigma-Aldrich).
Viral harvesting and infection
Lentiviral vectors were packaged and harvested in HEK 293T
cells using 10 mg of pCLGIT (or mutant kB/Sp1 variants), 5 mg
pMDLg/pRRE, 3.5 mg pVSV-G, and 1.5 mg pRSV-Rev, as
previously described [9,84], then concentrated by ultracentrifuga-
tion to yield between 10
7 and 10
8 infectious units/ml. For titering,
3610
5 Jurkat cells in 12-well plates were infected with approxi-
mately 10
3–10
6 infectious units per well. Six days later, infected
Jurkats were incubated with a combination of 5 mM HMBA,
20 ng/ml TNF-a, and 400 nM TSA for 18 hours and then
analyzed by flow cytometry to determine infectious titer by GFP
expression. This combination of agents was chosen to stimulate the
promoter via P-TEFb [85], NF-kB [36], and Sp1 dependent
mechanisms [37]. Titering curves were constructed to achieve
infection of 5–10% of cells after maximum stimulation, corre-
sponding to MOI ,0.05–0.10.
FACS analysis and sorting
Infected cultures were analyzed via flow cytometry on a Beckman-
Coulter EPICS XL-MCL cytometer (http://biology.berkeley.edu/
crl/cell_sorters_analysers.html). All flow measurements were per-
formedinparallelwithanuninfectedJurkatcontrol,andperturbation
experiments with TNF-a and TSA were performed in parallel with
stimulated but uninfected Jurkat controls. To isolate infected,
expressing populations, GFP
+ cells were sorted on a DAKO-
Cytomation MoFlo Sorter. As described in the text, bulk population
(polyclonal) and single cell (clonal) sorts were performed for a range of
different GFP positive regions, as follows: LGIT bulk and clonal sorts:
‘‘Off’’ region (,0.1–2.0 Relative Fluorescence Units), ‘‘Mid’’ region
(,2.0–30 RFU), ‘‘Bright’’ region (,30–1024 RFU), and ‘‘On’’
region (,2.0–1024 RFU). Flow cytometry data analysis was
performed with FlowJo (Tree Star, Inc.).
Analysis of gene expression by flow cytometry
Gene expression levels were tracked over a 21-day time course
by measuring the fluorescence intensity of GFP in LGIT and
mutant cells. Cells were infected at an MOI ,0.05–0.10, and a
GFP+ population was detectable by flow cytometry 48 hours after
infection. The time to peak activity occurred approximately one
week after infection; however, a bimodal distribution of infected
cells (‘‘Off’’ and ‘‘Bright’’) persisted throughout the three week
experiment. The strength of Tat-transactivation was measured by
examining the Bright population, and in particular, the mean of
this population (Bright Mean) was used as a marker of the base
efficiency of transactivated gene expression. The Bright Mean of
infected LGIT and mutants was determined by calculating the
average relative fluorescence of cells within the ‘‘Bright’’ region
(,30–1024 RFU).
For LGIT and all mutants, a small fraction of cells occurs in a
critical region defined as the Mid region (,2.0–30 RFU), which
lies between Off (,0.1–2.0 RFU) and Bright (,30–1024 RFU)
populations. Cells isolated from this region tend to turn Off or
Bright in a random fashion, demonstrating an instability of that
region [9]. The fraction of infected cells persisting in the Mid
region at a specific time is represented by the Mid:On ratio, in
which the On region (,2.0–1024 RFU) is the sum of Mid and
Bright subpopulations. We employ this ratio as a metric for
transcriptional instability, such that a high Mid:On ratio suggests
an unstable promoter and a high degree of stochastic switching.
Chromatin immunoprecipitation and quantification by
QPCR analysis
FACS sorting was performed to isolate Off and Bright fractions
of the LGIT and LGIT mutant cell lines, and 1610
6 cells were
acquired for each sort. Off, Bright, and original unsorted
populations were expanded to achieve 5610
7 cells, incubated in
1% formaldehyde for 10 minutes at room temperature for
fixation, and subsequently incubated with 125 mM glycine for
5 minutes at room temperature to quench the formaldehyde.
Upstate EZ ChIP (17–371) reagents and protocol were utilized for
crosslinking, lysis, sonication, immunoprecipitation, elution, re-
verse crosslinking, and DNA purification procedures. Sonication
was performed with the Branson Sonifier 450 for 15 cycles with
power output of 2.5, 10% duty cycle, for 10–15 second pulses and
1 minute intervals on ice. DNA was sheared to achieve an average
of 0.2–0.7 kb, as confirmed by DNA gel electrophoresis.
Immunoprecipitations were performed with Upstate polyclonal
antibodies anti-p50 (06–886), anti-p65 (06–418), anti-p300 (05–
257), anti-Sp1 (07–645), and anti-AcH3H9/14 (06–599) and
Abcam polyclonal antibodies anti-HDAC1 (ab7028), anti-H3
(ab1791), and anti-TriMetH3K9 (ab8898).
Immunoprecipitated DNA was quantified using quantitative
polymerase chain reaction (QPCR) with primers within the HIV
LTR which flank the kB and Sp1 elements [46]. To accurately
assess the input of each QPCR reaction, and to normalize for the
efficiency of immunoprecipitation of each antibody, we used
endogenous promoters containing functional kB and/or Sp1
domains as normalization controls for RelA, p300, and Sp1. The
endogenous TAP1/LMP2 regulatory domain (PubMed accession#
NM_000593.5), which contains a single kB site four nucleotides
downstream of an Sp1 site, was used to normalize QPCR data
from RelA and p50 immunoprecipitations, as this promoter has
been shown to constitutively recruit both p50-RelA and Sp1 [86].
Similarly, the endogenous BCL2L1 regulatory domain (PubMed
accession# NW_001838664.2), which contains Sp1 elements and
has been shown to strongly recruit p300 and Sp1 [87], was used
for normalizing QPCR data from p300 and Sp1 immunoprecip-
itations. Non-normalized ChIP results are presented in Figure S4,
and all ChIP primer sequences are provided in Table S2.
HDAC1, AcH3, TriMeH3, and H3 immunoprecipitations were
normalized by inputs, and acetylated histone 3 is reported as a
ratio of AcH3:H3 immunoprecipitations.
Amplified DNA products from each primer set were cloned into
the Invitrogen pCR2.1 plasmid (pCR2.1-TOPO-LTRkB,
pCR2.1-TOPO-TAP1/LMP2, and pCR2.1-TOPO-BCL2L1) to
create plasmids that were subsequently used to generate standard
curves for all QPCR analyses. Linear regression of standard curves
was achieved by serial dilutions ranging from ,10 ng to
,10
26 ng plasmid DNA, which corresponds to ,2610
9 to
,2610
2 copies per 20 mL reaction. Quantitative PCR was
performed using the iCycler iQ Real-Time PCR Detection
System (Bio-Rad, Hercules, CA), and SYBR Green I (Invitrogen)
was used as the fluorescent nucleic acid stain.
mRNA extraction and quantification by RT-PCR
As performed in ChIP experiments, FACS sorting was used to
isolate Off and Bright fractions of the LGIT and LGIT mutant cell
lines, and 1610
6 cells were acquired for each sort. Off and Bright
Sp1 and kB Sites Regulate HIV Latency
PLoS Pathogens | www.plospathogens.org 14 January 2009 | Volume 5 | Issue 1 | e1000260populations were expanded to achieve 1610
7 cells, total mRNA
was isolated using Trizol (Invitrogen), and transcripts were
quantified using the QuantiTect SYBR Green RT-PCR kit
(Qiagen) on the Bio-Rad iCycler. The total number of transcripts
(initiated and elongated) were detected with TAR primers [3], and
Tat primers were used to detect only elongated transcripts
(sequences in Table S3). For each sample, initiated and elongated
transcript levels were normalized by the corresponding levels of b-
Actin mRNA (sequences in Table S3) [9]. Measurements and
calculations of initiated, elongated, and truncated transcripts are
provided in Figure S5. Triplicate RT-PCR measurements were
performed for all samples for each primer set, and melt curves
were performed on the Bio-Rad iCycler for all samples to confirm
the specificity of QPCR reaction.
Supporting Information
Figure S1 Transcriptional Profiles of LGIT and LGIT Mutant
Time Course Infections. (A) As described in Figure 2, LGIT and
corresponding Sp1 and kB mutants were infected in Jurkat cells at
low MOI (,0.05–0.10) in biological triplicate, and GFP expression
was monitored over a 21-day time course. Histograms from each
replicate for each day were used to generate a heat map for days 2–
13 of the time course. The heat map indicates the distribution of
GFP fluorescence (y-axis) for each LGIT variant and how this
distribution changes over time (x-axis). The heat map reflects the
GFP fluorescence beyond the autofluorescence threshold, which is
set at 2.0 relative fluorescence units (RFU). The depicted region is
the sum of ‘‘Mid’’ and ‘‘Bright’’ regions (Figure 1C), and is termed
the ‘‘On’’ region. Further details of data analyses are in available in
Materials and Methods. Two LGIT variants (mutALL Sp1 and mutIII
Sp1/mutI NF-kB) failed to generate a GFP+ population of cells after
infection at low MOI (,0.05–0.10) and were thus omitted from this
study (see Figure S1B). (B) LGIT and mutant infections (MOI
,0.05–0.15) are shown seven days after infection (filled grey). In
parallel,eachpopulationwasstimulated withTNF-a (red outline)or
TSA (blue outline) for 18 hours six days after infection. In addition
to the previously mentioned Sp1 and kB LGIT mutants, two other
mutant combinations (mutation of all Sp1 sites, mutALL Sp1,a n d
mutation of Sp1 site III and kB site I, mutIII Sp1/mutI NF-kB) failed
to generate a Bright population after infection and were negligibly
responsive to stimulation with TNF-a or TSA. Since infections with
these particular LGIT mutants failed to generate a Bright mode,
they were omitted from further study, as the focus of this
investigation was the molecular and functional differences between
Off and Bright modes in a bimodal population.
Found at: doi:10.1371/journal.ppat.1000260.s001 (12 MB TIF)
Figure S2 Increased Switching Dynamics for Sp1 Mutant PheB
Clones. (A) Transcriptional switching dynamics were measured for
one PheB clone for each LGIT variant. Off (red outline) and
Bright (blue outline) fractions were isolated with FACS, and flow
cytometry was used four days after sorting to measure the degree
of switching (see Figure 4D). Off and Bright switching measure-
ments were normalized by the distribution of cells in the unsorted
PheB clone (gray filled histogram). Cytometry measurements for
the unsorted PheB clones were performed at the same time as the
sorts. (B) Same as (A) with flow cytometry measurements
performed seven days after sorting. Cytometry measurements for
the unsorted PheB clones were performed at the same time as the
sorts. Refer to Figure 4E for quantitative results.
Found at: doi:10.1371/journal.ppat.1000260.s002 (2.1 MB TIF)
Figure S3 Latent mutI NF-kB Retains Occupancy of p50-p50
Homodimer but not p50-RelA Heterodimer. (A) p50 ChIP results
for Off-sorted and Bright-sorted populations of LGIT, mutI NF-kB,
and mutII NF-kB as well as TNF-a-stimulated WT LGIT.
Immunoprecipitations were performed using p50 antibody, and
immunoprecipitated DNA was quantified using QPCR with
primers against the HIV LTR. For normalization of input DNA
and p50 immunoprecipitation, all LTR QPCR measurements
were normalized by with ChIP-QPCR measurements for the
endogenous TAP1/LMP2 regulatory domain, which contains
single kB and Sp1 sites recruits RelA and p50 (20). Primer
sequences and QPCR conditions for HIV LTR and TAP1/LBP2
are supplied in Materials and Methods. The QPCR measurements
for LTR and control TAP1/LBP2 were performed in triplicate,
and error bars are standard deviations. For all panels in Figure S3,
statistically significant differences from the corresponding sort for
WT LGIT are denoted by single asterisks (*, p,0.01) and double
asterisks (**, p,0.05). (B–D) Calculations of p50-p50 homodimers
and p50-RelA heterodimers for Off-sorted and Bright-sorted
populations of LGIT, mutI NF-kB and mutII NF-kB and TNF-a-
stimulated WT LGIT.W TLGIT was stimulated with TNF-a
(20 ng/ml, incubated for 30 minutes before crosslinking), and
ChIP was performed using p50 and RelA antibodies. Since TNF-a
induces nuclear localization of RelA, for the purposes of an
approximate calculation, all NF-kB bound to the kB sites of the
LTR can be approximated as p50-RelA heterodimer and none as
p50-p50 homodimer. With this assumption, and the supposition
that stimulation with TNF-a results in the maximum induced
levels of p50 and RelA bound to the HIV LTR, we calculated the
maximum normalized concentrations of p50 (p50max=1.86) and
RelA (RelAmax=7.6). The ratio of induced measurements of RelA
to p50 (7.6/1.86=4.1) corresponds to the relative efficiency in
RelA and p50 immunoprecipitations. Let the variables x and y be
the concentrations of p50-p50 homodimer and p50-RelA
heterodimer, respectively. Let z be the total concentration of
NF-kB, so that z=x+y. Since RelA only exists in the p50-RelA
heterodimer form, y is equal to be the normalized measurement of
RelA from ChIP. Since both p50-p50 homodimer and p50-RelA
heterodimer contain p50, then z=(RelAmax/p50max)6p50sample,
or z=4.16p50sample. Thus, x=z–y,s ox=4.16p50sample–RelA-
sample. Calculations of total NF-kB( z, panel B), p50-p50
homodimer (x, panel C), and p50-RelA heterodimer (y, panel D)
were performed for Off-sorted and Bright-sorted populations of
LGIT, mutI NF-kB, and mutII NF-kB.
Found at: doi:10.1371/journal.ppat.1000260.s003 (1.5 MB TIF)
Figure S4 Non-normalized ChIP QPCR as a Percentage of
Input DNA. (A) As performed in Figure S3, ChIP QPCR results as
a percentage of input against p50 for Off- and Bright-sorted LGIT,
mutI NF-kB, and mutII NF-kB and TNF-a-induced WT LGIT.
Denoted are the HIV LTR (white bars) and the control gene,
TAP1/LBP2 (gray bars). mutI Sp1, mutII Sp1, and mutIII Sp1 were
not performed. (B) As performed in Figure 6B, ChIP QPCR
results as a percentage of input DNA against RelA for Off- and
Bright-sorted LGIT, mutI Sp1, mutII Sp1, mutIII Sp1, mutI NF-kB,
and mutII NF-kB and TNF-a-induced WT LGIT. Denoted are the
HIV LTR (white bars) and the control gene, TAP1/LMP2 (gray
bars). This is the same control gene as used for p50. (C) As
performed in Figure 6C, ChIP QPCR results as a percentage of
input against p300 for Off- and Bright-sorted LGIT, mutI Sp1, mutII
Sp1, mutIII Sp1, mutI NF-kB, and mutII NF-kB. Denoted are the
HIV LTR (white bars) and the control gene, BCL2L1 (gray bars).
(D) As performed in Figure 6D, ChIP QPCR results as a
percentage of input against Sp1 for Off- and Bright-sorted LGIT,
mutI Sp1, mutII Sp1, mutIII Sp1, and mutI NF-kB. Denoted are the
HIV LTR (white bars) and the control gene, BCL2L1 (gray bars).
This is the same control gene as used for p300 and mutII NF-kB,
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percentage of input against trimethylated histone 3 lysine 9
(TriMetH3K9) for Off- and Bright-sorted LGIT, mutI Sp1, mutII
Sp1, mutIII Sp1, mutI NF-kB, and mutII NF-kB. Off-sorts are
denoted by white bars, Bright-sorts are denoted by black bars, and
uninfected Jurkat is denoted by the gray bar. Note that no samples
exceed the background (uninfected) control, indicating that
TriMetH3K9 is below detection levels.
Found at: doi:10.1371/journal.ppat.1000260.s004 (1.8 MB TIF)
Figure S5 Calculations of Truncated Transcripts by RT-PCR.
(A–B) As performed in Figures 6G–H, real time RT-PCR analysis
on initiated and fully elongated transcripts for Off- and Bright-
sorted LGIT, mutIII Sp1, mutI NF-kB, mutII NF-kB, and mutI&II
NF-kB. Off and Bright sorts were performed as in Figure 6A, and
cells were expanded for approximately one week before mRNA
extraction. Details for mRNA preparation QPCR are in Materials
and Methods in the main text. Initiated transcripts were detected
with primers for TAR, and elongated transcripts were detected
with primers for Tat. For both panels, statistically significant
differences from the corresponding sort for WT LGIT are denoted
by single asterisks (*, p,0.01) and double asterisks (**, p,0.05).
Found at: doi:10.1371/journal.ppat.1000260.s005 (0.92 MB TIF)
Figure S6 Stabilizing and Destabilizing Phenotypes for Off and
Bright Modes. (A) Summary of molecular and transcriptional
phenotypes in the inactive (Off) transcriptional mode. Measure-
ments for WT LGIT are assigned a ‘‘0’’ value, and comparisons for
each mutant to WT LGIT are denoted by increases (+), decreases
(2), and unchanged (0) values. Potential changes to the stabilities
of the Off mode are indicated by green (stabilizing) and red
(destabilizing) boxes. Measurements denoted with ‘‘NP’’ (black
boxes) were not performed. (B) Same as in (A) for the active
(Bright) transcriptional mode. Potential changes to the stabilities of
the Bright mode are indicated by green (stabilizing) and red
(destabilizing) boxes. Measurements denoted with ‘‘NP’’ (black
boxes) were not performed. (C) Differential regulation of the Off
and Bright modes was determined by examining phenotypic
differences in the Off- and Bright-sorts and dynamic switching
between modes. For ChIP measurements, statistically significant
increases (+), decreases (2), and unchanged (0) values for Bright
sorts, compared to the Off-sorted fractions, are denoted. For
switching and dynamics phenotypes, mutant values are compared
to the WT LGIT counterpart, as in (A) and (B). Differential
regulation of Off and Bright modes is indicated by green (strongly
regulated) and red (disregulated) boxes. Measurements denoted
with ‘‘NP’’ (black boxes) were not performed.
Found at: doi:10.1371/journal.ppat.1000260.s006 (1.5 MB TIF)
Table S1 Quikchange Primer Sequences for LGIT mutants
Found at: doi:10.1371/journal.ppat.1000260.s007 (0.04 MB
DOC)
Table S2 Primer Sequences for ChIP QPCR
Found at: doi:10.1371/journal.ppat.1000260.s008 (0.03 MB
DOC)
Table S3 Primer Sequences for Quantitect RT-PCR
Found at: doi:10.1371/journal.ppat.1000260.s009 (0.03 MB
DOC)
Table S4 Non-normalized Bright Mean Position (RFU)
Found at: doi:10.1371/journal.ppat.1000260.s010 (0.03 MB
DOC)
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